Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo

This study has been completed.
Information provided by:
St. Luke's-Roosevelt Hospital Center Identifier:
First received: June 2, 2006
Last updated: February 18, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)